Preview

Rheumatology Science and Practice

Advanced search

FIRST EXPERIENCE OF CYMEVEN IN THE COMBINED THERAPY OF RHEUMATOID ARTHRITIS

https://doi.org/10.14412/1995-4484-2001-480

Abstract

Ummary Objective. To reveal J'reguency of accompaning virus infection and possibility to use antivirus therapy together in therapy RA. Material. 40 patients with RA at the age of 17-45 were studied. The duration of disease was not more than 6 months; patients had 2-3 degrees of activity. Every one had a positive rheumatoid factor. Results. 78,2% of the examined patients connected the beginning of the illness with virus infection they have had. The most difficalt variant of RA course and uneffectiveness of basic therapy were registerd among the patients with combination HSV and CMV infection. Inclusion of Cymevene in complex therapy RA has exerted positive influence on clinical-laboratory, signs stregthened effect of basic therapy. Conclusion. The most difficult variant of RA course was registered among the patients with virus infection. Inclusion of antivirus drugs had a positive influence on effectiveness of basic therapy.

References

1. <div><p>Балабанова P.M., Егорова О.Н. Интерферонотерапия при ревматических заболеваниях. Русс. мед. "журнал, 1997,5-15,992-996.</p><p>Егорова О.Н., Балабанова P.M. Система интерферона при ревматических заболеваниях. Клнннч. ревма- тол., 1993, 2, 23-26.</p><p>Егорова О.Н., Балабанова P.M. Применение иммуномодулятора реальдирона в терапии ревматоидного артрита. Клинич. ревматол. 1996, 3, 52-54</p><p>Егорова О.Н., Балабанова P.M., Чувиров Г.И. Значение выявляемых при ревматических заболеваниях антител к вирусам семейства Herpesviridae. Тер. архив, 1998,5,4Ы5.</p><p>Насонова В.А.Бунчук Н.В. Ревматические болезни. М., “Медицина”, 1997,257-304.</p><p>Banki К., Ablonczy Е., Nakamura М. et al. Effect of p 40 tax activator of Human T Cell lymphotropic virus type I on expression of autoantigens. AIDS Res. Hum. Petrov. 1994,10,303-8.</p><p>Haster F., Bluestein H.G., Zvaifler N.I. ct al. Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced В cell proliferation by rheumatoid arthritis lymphocytes. J. exp. Med., 1983, 157, 171-183.</p><p>Hooks J., Moutsopoulos Н., Geis S. et al, Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med., 1979, 301.5-8.</p><p>Kohn L.D. Kosugi S. Ban T. et al. Molecular basic for the auloreactivity against thyroid stimulating hormone receptor. Rev, Immunol., 1992, 9, 135-65.</p><p>Mousavi-Jazi М., Bostrotn L., Lovmark et al. Infrequent detection of CMV and EBV DNA in sinovial membrane of patients with RA. J.Rheum., 1998, 25, 623-8.</p><p>Phillips P.E. Viral arthritis. Curr. Opin. Rheumat., 1997, 9, 337-44.</p><p>Saal J.G., Krimmel М., Steidle M et al. Sinovial EBV infection increases the risk of RA in individuals with the shared HLA-DR 4 epitope. Arthr.Rheum., 1999,42,7, 1485-1496.</p><p>Slaughter L. Carson D.A., Jensen F.C. et al. In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects. J. Exp. Med., 1978. 148, 1429-1434.</p><p>Stahl H-D, Hubner B. Seidl В et al. Detection of multipl viral DNA species in synovial tissue and fluid of patients with early arthritis. Ann.Rheum. Dis,, 2000, 59, 342-346.</p><p>Takahashi J. Murai C.„Shibata S. et al. Human parvovirus В 19 as a causative agent for RA. Prac. Nat.Acad. Sci USA, 1998,95,8227-32.</p><p>Takeda Т., Mizngaki J., Matsubara L. et al. Lytic EBV infection in the synovial tissue of patients with RA. Arthr. Reum. 2000,43,6,1218-1225.</p><p>Van der Heijde D.M. Joint erosions and patients with early RA. Br. J. Rheum., 1995, 34, 2, 74-8.</p><p>Vanghan J.H. Viruses and autoimmune disease. J. Rheum., 1996.23,1831-3.</p><p>Winchester R. The molecular basis of susceptibility to RA. Adv. Immnol., 1994, 56, 389-466.</p><p>Wolf F., Cathey M.A. The assessment and prediction of functional disability in RA. J. Rheum., 1991, 18, 1296306.</p></div><br />


Review

For citations:


Balabanova R.M., Salnikova T.S. FIRST EXPERIENCE OF CYMEVEN IN THE COMBINED THERAPY OF RHEUMATOID ARTHRITIS. Rheumatology Science and Practice. 2001;39(5):87-91. (In Russ.) https://doi.org/10.14412/1995-4484-2001-480

Views: 2875


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)